"10.1371_journal.pone.0071375","plos one","2013-08-06T00:00:00Z","Ales Tichopad; Craig Roberts; Igor Gembula; Petr Hajek; Anna Skoczynska; Waleria Hryniewicz; Karina Jahnz-Rozyk; Roman Prymula; Ivan Solovič; Vitězslav Kolek","CEEOR spol. s r.o., Prague, Czech Republic; Emerging Markets Business Unit, Pfizer Inc., Collegeville, Pennsylvania, United States of America; Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland; Department of Immunology & Allergology, Military Institute of Health Service, Warsaw, Poland; University Hospital Hradec Kralove, Hradec Kralove, Czech Republic; I. Department of Pneumology and Ftizeology, National Institute for Tuberculosis, Lung Diseases and Thoracic Surgery, Vysne Hagy, Slovakia; Department of Pulmonary Diseases and Tuberculosis, University Hospital Olomouc, Olomouc, Czech Republic","Conceived and designed the experiments: AT CR IG PH. Performed the experiments: AT VK IG. Analyzed the data: AT IG. Contributed reagents/materials/analysis tools: AS WH KJR RP IS VK. Wrote the paper: AT CR.","The authors have the following interests. This study was sponsored by Pfizer Inc. CR and PH are employees and shareholders in Pfizer Inc. AT and IG are employed by CEEOR spol. s r.o. AT and IG have received a reimbursement for attending a symposium, a fee for speaking and funds for research; AS received a reimbursement for attending a symposium, a fee for speaking, a fee for organizing education, funds for research, funds for a member of staff and fees for consulting; VH has received a reimbursement for attending a symposium, a fee for speaking and fees for consulting. PR has received a reimbursement for attending a symposium, a fee for speaking, and fees for consulting and funds for research from Pfizer Inc. in the past five years. KJH has served as a principal investigator in clinical trials (A7881013, A6631029) sponsored by Pfizer Inc. in the past five years. VK has no conflict of interest. Pfizer Inc. develops and markets medicines and vaccines for the treatment and prevention of pneumonia. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","08","Ales Tichopad","AT",10,TRUE,4,3,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
